Quick Dispatch:
Your glp 1 roche GLP-1-based therapies for diabetes, obesity and beyond orders ship within 1-2 business days.
Delivery Options:
Order Tracking:
You'll receive a tracking link by email once your glp 1 roche GLP-1-based therapies for diabetes, obesity and beyond ships.
Need Help?
Questions about glp 1 roche GLP-1-based therapies for diabetes, obesity and beyond, sizing, or delivery? We're just an email away.
Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for glp 1 roche GLP-1-based therapies for diabetes, obesity and beyond in your area.
![Ad hoc announcement pursuant to Art. 53 LR] Roche announces positive Phase I results of its oral GLP-1 receptor agonist CT-996 for the treatment of people with obesity](https://a.storyblok.com/f/176343/1920x1281/9879d12165/roche_270354.jpeg)
Ad hoc announcement pursuant to Art. 53 LR] Roche announces positive Phase I results of its oral GLP-1 receptor agonist CT-996 for the treatment of people with obesity
22.44
⚡️ 𝗥𝗼𝗰𝗵𝗲 𝗷𝘂𝘀𝘁 𝗽𝗼𝘀𝘁𝗲𝗱 𝗣𝗵𝗮𝘀𝗲 𝟮 𝗼𝗯𝗲𝘀𝗶𝘁𝘆 𝗱𝗮𝘁𝗮 𝘁𝗵𝗮𝘁 𝗿𝗶𝘃𝗮𝗹 𝗭𝗲𝗽𝗯𝗼𝘂𝗻𝗱... 𝗬𝗲𝗮𝗿𝘀 𝗹𝗮𝘁𝗲 𝘁𝗼 𝗮 $𝟭𝟬𝟬𝗕 𝗿𝗮𝗰𝗲. Roche has released Phase 2 results for CT-388, a dual GLP-1/GIP injectable obesity
21.35
Roche, trailing in obesity, showcases new data for GLP-1 shot
27.17
Roche GLP-1 produces “robust” weight loss in late-stage obesity trial | News
20.61
#LaRochePosayPartner GLP-1 medications can change how skin looks due to hydration shifts and volume loss. Using Hyalu B5 Suractivated Serum + Cream helps support hydration and the look of elasticity
27.40
Roche's Novel Dual GLP-1/GIP Receptor Agonist Produces Clinically Meaningful Weight Loss in Phase Ib Trial
22.30
Roche plans to become top 3 obesity player as CT-388 enters trial
21.82
